AAAAAA

   
Results: 1-25 | 26-50
Results: 1-25/50
INTERMEDIATE-DOSE METHOTREXATE IS AS EFFECTIVE AS HIGH-DOSE METHOTREXATE IN PREVENTING ISOLATED TESTICULAR RELAPSE IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: DORDELMANN M REITER A ZIMMERMANN M FENGLER R HENZE G RIEHM H SCHRAPPE M
Citation: M. Dordelmann et al., INTERMEDIATE-DOSE METHOTREXATE IS AS EFFECTIVE AS HIGH-DOSE METHOTREXATE IN PREVENTING ISOLATED TESTICULAR RELAPSE IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, Journal of pediatric hematology/oncology, 20(5), 1998, pp. 444-450
THE TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - THE INTERNATIONAL BFM STUDY-GROUP EXPERIENCE
Authors: MASERA G GADNER H KAMPS WA OTTEN J PHILIPPE N SCHULER D RIEHM H
Citation: G. Masera et al., THE TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - THE INTERNATIONAL BFM STUDY-GROUP EXPERIENCE, International journal of pediatric hematology/oncology, 5(2-4), 1998, pp. 141-144
IMMUNOPHENOTYPE AND CLINICAL CHARACTERISTICS OF CD45-NEGATIVE AND CD45-POSITIVE CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: RATEI R SPERLING C KARAWAJEW L SCHOTT G SCHRAPPE M HARBOTT J RIEHM H LUDWIG WD
Citation: R. Ratei et al., IMMUNOPHENOTYPE AND CLINICAL CHARACTERISTICS OF CD45-NEGATIVE AND CD45-POSITIVE CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, Annals of hematology, 77(3), 1998, pp. 107-114
DOWNS-SYNDROME IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - CLINICAL CHARACTERISTICS AND TREATMENT OUTCOME IN 4 CONSECUTIVE BFM TRIALS
Authors: DORDELMANN M SCHRAPPE M REITER A ZIMMERMANN M GRAF N SCHOTT G LAMPERT F HARBOTT J NIEMEYER C RITTER J DORFFEL W NESSLER G KUHL J RIEHM H
Citation: M. Dordelmann et al., DOWNS-SYNDROME IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - CLINICAL CHARACTERISTICS AND TREATMENT OUTCOME IN 4 CONSECUTIVE BFM TRIALS, Leukemia, 12(5), 1998, pp. 645-651
PREVENTION OF CNS RECURRENCE IN CHILDHOOD ALL - RESULTS WITH REDUCED RADIOTHERAPY COMBINED WITH CNS-DIRECTED CHEMOTHERAPY IN 4 CONSECUTIVE ALL-BFM TRIALS
Authors: SCHRAPPE M REITER A HENZE G NIEMEYER C BODE U KUHL J GADNER H HAVERS W PLUSS H KORNHUBER B ZINTL F RITTER J URBAN C NIETHAMMER D RIEHM H
Citation: M. Schrappe et al., PREVENTION OF CNS RECURRENCE IN CHILDHOOD ALL - RESULTS WITH REDUCED RADIOTHERAPY COMBINED WITH CNS-DIRECTED CHEMOTHERAPY IN 4 CONSECUTIVE ALL-BFM TRIALS, Klinische Padiatrie, 210(4), 1998, pp. 192-199
PROPHYLAXIS AND TREATMENT OF NEOPLASTIC MENINGEOSIS IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: SCHRAPPE M REITER A RIEHM H
Citation: M. Schrappe et al., PROPHYLAXIS AND TREATMENT OF NEOPLASTIC MENINGEOSIS IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, Journal of neuro-oncology, 38(2-3), 1998, pp. 159-165
PROGNOSTIC VALUE OF MINIMAL RESIDUAL DISEASE IN ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDHOOD
Authors: VANDONGEN JJM SERIU T PANZERGRUMAYER ER BIONDI A PONGERSWILLEMSE MJ CORRAL L STOLZ F SCHRAPPE M MASERA G KAMPS WA GADNER H VANWERING ER LUDWIG WD BASSO G DEBRUIJN MAC CAZZANIGA G HETTINGER A VANDERDOESVANDENBERG A HOP WCJ RIEHM H BARTRAM CR
Citation: Jjm. Vandongen et al., PROGNOSTIC VALUE OF MINIMAL RESIDUAL DISEASE IN ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDHOOD, Lancet, 352(9142), 1998, pp. 1731-1738
HOFMANN,FRIEDRICH - IN-MEMORIAM
Authors: RIEHM H
Citation: H. Riehm, HOFMANN,FRIEDRICH - IN-MEMORIAM, Musik und Kirche, 68(4), 1998, pp. 296-297
IMMUNOPHENOTYPIC AND CLINICAL-FEATURES OF T-CELL RECEPTOR GAMMA-DELTA(-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA() T)
Authors: SCHOTT G SPERLING C SCHRAPPE M RATEI R MARTIN M MEYER U RIEHM H LUDWIG WD
Citation: G. Schott et al., IMMUNOPHENOTYPIC AND CLINICAL-FEATURES OF T-CELL RECEPTOR GAMMA-DELTA(-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA() T), British Journal of Haematology, 101(4), 1998, pp. 753-755
PHILADELPHIA-CHROMOSOME-POSITIVE (PH-LEUKEMIA - GOOD INITIAL STEROID-RESPONSE ALLOWS EARLY PREDICTION OF A FAVORABLE TREATMENT OUTCOME() CHILDHOOD ACUTE LYMPHOBLASTIC)
Authors: SCHRAPPE M ARICO M HARBOTT J BIONDI A ZIMMERMANN M CONTER V REITER A VALSECCHI MG GADNER H BASSO G BARTRAM CR LAMPERT F RIEHM H MASERA G
Citation: M. Schrappe et al., PHILADELPHIA-CHROMOSOME-POSITIVE (PH-LEUKEMIA - GOOD INITIAL STEROID-RESPONSE ALLOWS EARLY PREDICTION OF A FAVORABLE TREATMENT OUTCOME() CHILDHOOD ACUTE LYMPHOBLASTIC), Blood, 92(8), 1998, pp. 2730-2741
GRANULOCYTE-COLONY-STIMULATING FACTOR IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: WELTE K RIEHM H
Citation: K. Welte et H. Riehm, GRANULOCYTE-COLONY-STIMULATING FACTOR IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA, The New England journal of medicine, 337(18), 1997, pp. 1320-1320
HIGH-INCIDENCE OF SIGNIFICANT BONE LOSS IN PATIENTS WITH SEVERE CONGENITAL NEUTROPENIA (KOSTMANNS-SYNDROME)
Authors: YAKISAN E SCHIRG E ZEIDLER C BISHOP NJ REITER A HIRT A RIEHM H WELTE K
Citation: E. Yakisan et al., HIGH-INCIDENCE OF SIGNIFICANT BONE LOSS IN PATIENTS WITH SEVERE CONGENITAL NEUTROPENIA (KOSTMANNS-SYNDROME), The Journal of pediatrics, 131(4), 1997, pp. 592-597
EXPRESSION OF INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) IN CHILDHOODACUTE LYMPHOBLASTIC-LEUKEMIA - CORRELATION WITH CLINICAL-FEATURES ANDOUTCOME
Authors: MIELCAREK M SPERLING C SCHRAPPE M MEYER U RIEHM H LUDWIG WD
Citation: M. Mielcarek et al., EXPRESSION OF INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) IN CHILDHOODACUTE LYMPHOBLASTIC-LEUKEMIA - CORRELATION WITH CLINICAL-FEATURES ANDOUTCOME, British Journal of Haematology, 96(2), 1997, pp. 301-307
INCIDENCE AND CLINICAL RELEVANCE OF TEL AML1 FUSION GENES IN CHILDRENWITH ACUTE LYMPHOBLASTIC-LEUKEMIA ENROLLED IN THE GERMAN AND ITALIAN MULTICENTER THERAPY TRIALS/
Authors: BORKHARDT A CAZZANIGA G VIEHMANN S VALSECCHI MG LUDWIG WD BURCI L MANGIONI S SCHRAPPE M RIEHM H LAMPERT F BASSO G MASERA G HARBOTT J BIONDI A
Citation: A. Borkhardt et al., INCIDENCE AND CLINICAL RELEVANCE OF TEL AML1 FUSION GENES IN CHILDRENWITH ACUTE LYMPHOBLASTIC-LEUKEMIA ENROLLED IN THE GERMAN AND ITALIAN MULTICENTER THERAPY TRIALS/, Blood, 90(2), 1997, pp. 571-577
BENEFIT OF INTENSIFIED CONSOLIDATION THERAPY WITH AND WITHOUT ALLOGENEIC BMT FOR SUBSETS OF HIGH-RISK ALL IN TRIAL ALL-BFM-90
Authors: REITER A EBELL W SCHRAPPE M HARBOTT J LUDWIG WD KLINGEBIEL T ZINTL F HENZE G GADNER H WELTE K RIEHM H
Citation: A. Reiter et al., BENEFIT OF INTENSIFIED CONSOLIDATION THERAPY WITH AND WITHOUT ALLOGENEIC BMT FOR SUBSETS OF HIGH-RISK ALL IN TRIAL ALL-BFM-90, Blood, 90(10), 1997, pp. 997-997
RISK-ORIENTED TREATMENT OF CHILDHOOD ALL - FAVORABLE OUTCOME DESPITE REDUCED INTENSITY OF TREATMENT IN TRIAL ALL-BFM-90
Authors: SCHRAPPE M REITER A SAUTER S GADNER H LAMPERT F RITTER J PLUESS J NIETHAMMER D HAVERS W DOERFFEL W ZIMMERMANN M WELTE K RIEHM H
Citation: M. Schrappe et al., RISK-ORIENTED TREATMENT OF CHILDHOOD ALL - FAVORABLE OUTCOME DESPITE REDUCED INTENSITY OF TREATMENT IN TRIAL ALL-BFM-90, Blood, 90(10), 1997, pp. 2488-2488
PREDNISONE GOOD RESPONSE (PGR) IDENTIFIES A SUBSET OF T(9-22) CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) AT LOWER RISK FOR EARLY LEUKEMIARELAPSE
Authors: ARICO M SCHRAPPE M HARBOTT J BASSO G REITER A CONTER V ZIMMERMANN M VALSECCHI MG GADNER H BIONDI A BARTRAM CR RIEHM H MASERA G
Citation: M. Arico et al., PREDNISONE GOOD RESPONSE (PGR) IDENTIFIES A SUBSET OF T(9-22) CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) AT LOWER RISK FOR EARLY LEUKEMIARELAPSE, Blood, 90(10), 1997, pp. 2494-2494
INCIDENCE AND CLINICAL OUTCOME OF CHILDREN WITH BCR ABL-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - A PROSPECTIVE RT-PCR STUDY BASED ON 673 PATIENTS ENROLLED IN THE GERMAN PEDIATRIC MULTICENTER THERAPY TRIALS ALL-BFM-90 AND COALL-05-92/
Authors: SCHLIEBEN S BORKHARDT A REINISCH I RITTERBACH J JANSSEN JWG RATEI R SCHRAPPE M REPP R ZIMMERMANN M KABISCH H JANKASCHAUB G BARTRAM CR LUDWIG WD RIEHM H LAMPERT F HARBOTT J
Citation: S. Schlieben et al., INCIDENCE AND CLINICAL OUTCOME OF CHILDREN WITH BCR ABL-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - A PROSPECTIVE RT-PCR STUDY BASED ON 673 PATIENTS ENROLLED IN THE GERMAN PEDIATRIC MULTICENTER THERAPY TRIALS ALL-BFM-90 AND COALL-05-92/, Leukemia, 10(6), 1996, pp. 957-963
CYTOREDUCTION AND PROGNOSIS IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: SCHRAPPE M REITER A RIEHM H
Citation: M. Schrappe et al., CYTOREDUCTION AND PROGNOSIS IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, Journal of clinical oncology, 14(8), 1996, pp. 2403-2405
10 YEARS TRANSPLANTATION OF BONE-MARROW A ND OF HEMATOPOIETIC STEM-CELLS AT THE MEDICAL-SCHOOL HANOVER
Authors: LINK H DIEDRICH H ARSENIEV L STOLL M EBELL W FREUND M TISCHLER J CASPER J HUBNER G SCHOFFSKI P DIEHL S GOES A JACOBS R KADAR J STANGEL W MULLER R RITTMANN KL WILDFANG I BUCSKY P BETTONI C SCHMIDT RE RIEHM H POLIWODA H
Citation: H. Link et al., 10 YEARS TRANSPLANTATION OF BONE-MARROW A ND OF HEMATOPOIETIC STEM-CELLS AT THE MEDICAL-SCHOOL HANOVER, Medizinische Klinik, 91, 1996, pp. 3-17
CLINICAL COURSE OF AUTOIMMUNE NEUTROPENIA IN INFANCY
Authors: ZEIDLER C BUX J RIEHM H WELTE K
Citation: C. Zeidler et al., CLINICAL COURSE OF AUTOIMMUNE NEUTROPENIA IN INFANCY, Experimental hematology, 24(9), 1996, pp. 273-273
THE ROLE OF THROMBOPOIETIN (TPO) AND ITS RECEPTOR C-MPL IN THE REGULATION OF THE THROMBOCYTOPOIESIS IN CHILDREN WITH VARIOUS THROMBOCYTOPENIAS
Authors: STRAUSS G BALLMAIER M SCHULZE H BOGENBERGER J RIEHM H WELTE K
Citation: G. Strauss et al., THE ROLE OF THROMBOPOIETIN (TPO) AND ITS RECEPTOR C-MPL IN THE REGULATION OF THE THROMBOCYTOPOIESIS IN CHILDREN WITH VARIOUS THROMBOCYTOPENIAS, Klinische Padiatrie, 208(4), 1996, pp. 168-171
WHICH CHILDREN DO BENEFIT FROM BONE-MARROW TRANSPLANT
Authors: NIETHAMMER D KLINGEBIEL T EBELL W HENZE G PAOLUCCI P RIEHM H
Citation: D. Niethammer et al., WHICH CHILDREN DO BENEFIT FROM BONE-MARROW TRANSPLANT, Bone marrow transplantation, 18, 1996, pp. 43-46
DURATION AND INTENSITY OF MAINTENANCE CHEMOTHERAPY IN ACUTE LYMPHOBLASTIC-LEUKEMIA - OVERVIEW OF 42 TRIALS INVOLVING 12,000 RANDOMIZED CHILDREN
Authors: RICHARDS S GRAY R PETO R GAYNON P MASERA G PESSION A RONDELLI R VALSECCHI MG REITER A RIEHM H SCHRAPPE M MCINTYRE OR BLEYER A CAIRO M REAMAN G SATHER H TRIGG M AUCLERC MF BANCILLON A LEPAGE E SCHAISON G CLAVELL L DATTON V DONNELLY M GELBER R SALLAN SE SACKMANMURIEL F SANTARELLI MT PEREZ C SOLIDORO A BAILEY C BURNETT A CHESSELLS J EDEN OB GORDONSMITH EC LILLEYMAN J LAND VJ MAHONEY D MURPHY S STEUBER CP VIETTI T CRIST W HANCOCK M PUI CH SIMONE J MITTRA I SHETTY PA ALLISON R BAIGENT C CLARKE M DUONG H DURRANT J GODWIN J GREAVES E HARWOOD C PETO J SINCLAIR D WHEATLEY K
Citation: S. Richards et al., DURATION AND INTENSITY OF MAINTENANCE CHEMOTHERAPY IN ACUTE LYMPHOBLASTIC-LEUKEMIA - OVERVIEW OF 42 TRIALS INVOLVING 12,000 RANDOMIZED CHILDREN, Lancet, 347(9018), 1996, pp. 1783-1788
DOES THE TEL AML1 EXPRESSION DEFINE A SUBGROUP OF PEDIATRIC ALL WITH A GOOD PROGNOSIS - THE RESULTS OF THE GERMAN (BFM) AND ITALIAN (AIEOP)ALL STUDY-GROUPS/
Authors: BORKHARDT A CAZZANIGA G LUDWIG WD MANGIONI S BURCI L SCHRAPPE M VALSECCHI MG RIEHM H LAMPERT F BASSO G MASERA G HARBOTT J BIONDI A
Citation: A. Borkhardt et al., DOES THE TEL AML1 EXPRESSION DEFINE A SUBGROUP OF PEDIATRIC ALL WITH A GOOD PROGNOSIS - THE RESULTS OF THE GERMAN (BFM) AND ITALIAN (AIEOP)ALL STUDY-GROUPS/, Blood, 88(10), 1996, pp. 1791-1791
Risultati: 1-25 | 26-50